Detection of a factor released by L5178Y lymphoblasts that inhibits mouse macrophage-activation induced by lipopolysaccharides

Archives of Medical Research

Volumn 30, Issue 4, 1999, Pages 298-302

  Palacios Corona, Rebeca ^a,b   Ortíz Navarrete, Vianney F ^a   Said Fernández, Salvador ^a   Rodríguez Padilla, Cristina ^b   González Garza, Ma Teresa ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

Macrophage inhibitor; MAIF; Nitric oxide; Peritoneal macrophage; Tumoral inhibitor factor

Indexed keywords

GAMMA INTERFERON; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES; CONTROLLED STUDY; LEUKEMIA L 5178 Y; LYMPHOBLAST; LYMPHOMA; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE;

EID: 0033167019     PISSN: 01880128     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0188-0128(99)00035-4     Document Type: Article

References (25)

1. Abbas A.K., Lichtman A.H., Pober J.S. Cellular and molecular immunology. 1995;McGraw Hill, New York.
2. Keller R., Keist R., Wechsler A., Leist T.P., Van der Meid P.H. Mechanisms of macrophage-mediated tumor cell killing. a comparative analysis of the roles of reactive nitrogen intermediates and tumor necrosis factor Int J Cancer. 46:1990;682.
3. Nong Y.H., North R.J., Kirstein D.P., Tuttle R.L. Subversion of host defense mechanisms by murine tumors, I. A circulating factor that suppresses macrophage-mediated resistance to infection. J Exp Med. 143:1976;559.
4. Szuro-Sudol A., Nathan C.F. Suppression of macrophage oxidative metabolism byproducts of malignant and nonmalignant cells. J Exp Med. 156:1982;945.
5. Siziopikou K.P., Harris J.E., Casey L., Nawas Y., Braun D.P. Impaired tumoricidal function of alveolar macrophages from patients with non-small cell lung cancer. Cancer. 68:1991;1035.
6. Calderón C., Huang Z.-H., Gage D.A., Sotomayor E.M., López D.M. Isolation of a nitric oxide inhibitor from mammary tumor cells and its characterization as phosphatidyl serine. J Exp Med. 180:1994;945.
7. Walker T.M., Burger C.J., Elgert K.D. Tumor growth alters T cell and macrophage production of and responsiveness to granulocyte-macrophage colony-stimulating factor. partial dysregulation through interleukin-10 Cell Immunol. 154:1994;342.
8. López D.M., Handel-Fernández M.E., Cheng X., Charyulu V., Herbert L.M., DiNapoli M.R., Calderón C.L. Cytokine production by lymphoreticular cells from mammary tumor bearing mice. the role of tumor-derived factors Anticancer Res. 16:1996;3923.
9. DiNapoli M.R., Calderón C.L., López D.M. Phosphatidyl serine is involved in the reduced rate of transcription of the inducible nitric oxide synthase gene in macrophages from tumor bearing mice. J Immunol. 158:1997;1810.
10. González-Garza M.T., Fernández-Quintero P., Arellano-Blanco J., Gómez-Estrada H. Autolysis induction of malignant lymphoblasts. Arch Invest Med. 9:1978;33.
11. Wiltrout R.H., Brunda M.J., Holden H.T. Variation in selectivity of tumor cell cytolysis by murine macrophages, macrophage-like cell lines and NK cells. Int J Cancer. 30:1982;335.
12. Stuehr D.J., Nathan C.F. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med. 169:1989;1543.
13. Hartree E.F. Determination of protein. a modification of Lowry method that gives a linear photometric response Anal Biochem. 48:1972;422.
14. Yurochko A.D., Burger C.J., Elgert K.D. Tumor modulation of autoreactivity. decreased macrophage and autoreactive T cell interactions Cell Immunol. 127:1990;105.
15. Yurochko A.D., Burger C.J., Elgert K.D. Normal and tumor-bearing host splenic macrophage responses to lipopolysaccharide. Immunol Invest. 19:1990;41.
16. Klobusicka M., Kusenda J. Cytochemical study of activated peritoneal macrophages in normal and tumor-bearing rats. Neoplasma. 39:1992;291.
17. Kusenda J., Kalafut F., Klobusicka M., Novotna L. Tumoricidal properties of rat peritoneal macrophages activated with various activators depend on nitrogen oxid synthesis. Neoplasma. 39:1992;15.
18. Srimal S., Nathan C. Purification of macrophage deactivating factor. J Exp Med. 171:1990;1347.
19. Rojas A., Delgado R., Glaria L., Palacios M. Monocyte chemotactic protein-1 inhibits the induction of nitric oxide synthase in J774 cells. Biochem Biophys Res Commun. 196:1993;274.
20. Tsunawaki S., Sporn M., Ding A., Nathan C.F. Deactivation of macrophages by transforming growth factor-β Nature. 334:1988;260.
21. Tsunawaki S., Sporn M., Nathan C. Comparison of transforming growth factor-β and a macrophage deactivating polypeptide from tumor cells. Difference in antigenicity and mechanism of action. J Immunol. 142:1989;3462.
22. Hirte H., Clark D.A. Generation of lymphokine-activated killer cells in human ovarian carcinoma ascitic fluid. identification of transforming growth factor-beta as a suppressive factor Cancer Immunol Immunother. 32:1991;296.
23. Vodovotz Y., Bogdan C., Paik J., Xie Q.-W., Nathan C.F. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β J Exp Med. 178:1993;605.
24. Bogdan C., Vodovotz Y., Nathan C. Macrophage deactivation by interleukin 10. J Exp Med. 174:1991;1549.
25. Weinstein S.L., Gold M.R., DeFranco A.L. Lipopolysaccharide induced protein tyrosine phosphorylation in human macrophages is mediated by CD14. J Immunol. 151:1993;3829.